Multiple Lawsuits Filed Against Novo Nordisk Over Vision Loss Linked to Ozempic and Wegovy
A growing number of New Jersey plaintiffs are taking legal action against Novo Nordisk, the pharmaceutical company behind the popular medications Ozempic and Wegovy. The plaintiffs allege that the semaglutide-based drugs caused them to suffer permanent vision loss due to a rare and irreversible eye condition, nonarteritic anterior ischemic optic neuropathy (NAION). With the support…
Details